China Pharma subsidiary to acquire captopril microcapsule patent for $6.3M in stock

CHINA PHARMA HOLDINGS, INC.

Hainan Helpson subsidiary to receive Captopril microcapsule invention patent and preparation method from Lijie Tang.
Transfer price of $6.3 million paid via 3,500,000 shares of CPHI common stock at $1.80 per share.
Transferor to provide technical services including product R&D, registration materials, and application support.
Shares issued as unregistered securities under Regulation S to a non-U.S. person.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

CHINA PHARMA HOLDINGS, INC. issued 3,500,000 restricted shares of Common Stock of common stock to Lijie Tang for $6.3 million, $1.80 per share.

Security: common stock
Shares: 3,500,000 restricted shares of Common Stock
Purchaser: Lijie Tang
Consideration: $6.3 million, $1.80 per share

Exact text from the filing

research and development, writing of registration materials, registration application and other technical services. The transfer price as contemplated by the Agreement is $6.3 million, which will be paid in the form of common stock of the Company, par value $0.001 per share (the “ Common Stock ”), at $1.80 per share. transfer price as contemplated by the

View on SEC.gov

Browse all equity issuances →

CHINA PHARMA HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001213900-25-120129

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.